{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:07:23Z","timestamp":1780448843585,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A20384"],"award-info":[{"award-number":["U20A20384"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015375","name":"Affiliated Hospital of Southwest Medical University","doi-asserted-by":"publisher","award":["2021ZKQN066"],"award-info":[{"award-number":["2021ZKQN066"]}],"id":[{"id":"10.13039\/501100015375","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-026-01434-8","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T20:48:18Z","timestamp":1776718098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FAPI PET\/CT shows favorable potential for the evaluation of gallbladder cancer: a prospective study comparing [68Ga]Ga-FAPI-04 and [18F]FDG"],"prefix":"10.1186","volume":"16","author":[{"given":"Dengsai","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiyong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4088-7649","authenticated-orcid":false,"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"1434_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ejso.2007.07.206","volume":"34","author":"G Miller","year":"2008","unstructured":"Miller G, Jarnagin WR. Gallbladder carcinoma. EJSO Eur J Surg Oncol. 2008;34:306\u201312.","journal-title":"EJSO Eur J Surg Oncol"},{"key":"1434_CR2","first-page":"171","volume":"75","author":"MT Carriaga","year":"1995","unstructured":"Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer-Am Cancer Soc. 1995;75:171\u201390.","journal-title":"Cancer-Am Cancer Soc"},{"key":"1434_CR3","doi-asserted-by":"publisher","first-page":"v28","DOI":"10.1093\/annonc\/mdw324","volume":"27","author":"JW Valle","year":"2016","unstructured":"Valle JW, Borbath I, Khan SA, Huguet F, Gruenberger T, Arnold D. Biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v28-37.","journal-title":"Ann Oncol"},{"key":"1434_CR4","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.3748\/wjg.v23.i22.3978","volume":"23","author":"A Sharma","year":"2017","unstructured":"Sharma A, Sharma KL, Gupta A, Yadav A, Kumar A. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update. World J Gastroenterol. 2017;23:3978\u201398.","journal-title":"World J Gastroenterol"},{"key":"1434_CR5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1055\/a-1161-3985","volume":"58","author":"D Walter","year":"2020","unstructured":"Walter D, Trojan J, Waidmann O. [Systemic Chemotherapy of gallbladder carcinoma - simply the same as for cholangiocarcinoma?]. Z Gastroenterol. 2020;58:583\u20139.","journal-title":"Z Gastroenterol"},{"key":"1434_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrc1429","volume":"4","author":"II Wistuba","year":"2004","unstructured":"Wistuba II, Gazdar AF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer. 2004;4:695\u2013706.","journal-title":"Nat Rev Cancer"},{"key":"1434_CR7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","volume":"8","author":"B Blechacz","year":"2011","unstructured":"Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:512\u201322.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1434_CR8","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.3748\/wjg.v20.i16.4574","volume":"20","author":"CX Wu","year":"2014","unstructured":"Wu CX, Zhu ZH. Diagnosis and evaluation of gastric cancer by positron emission tomography. World J Gastroenterol. 2014;20:4574\u201385.","journal-title":"World J Gastroenterol"},{"key":"1434_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.radonc.2021.02.015","volume":"158","author":"L Zhao","year":"2021","unstructured":"Zhao L, Chen S, Chen S, Pang Y, Dai Y, Hu S, et al. 68Ga-fibroblast activation protein inhibitor PET\/CT on gross tumour volume delineation for radiotherapy planning of oesophageal cancer. Radiother oncol. 2021;158:55\u201361.","journal-title":"Radiother oncol"},{"key":"1434_CR10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, et al. 68Ga-FAPI PET\/CT: Tracer Uptake in 28 Different Kinds of Cancer. J Nucl Med. 2019;60:801\u20135.","journal-title":"J Nucl Med"},{"key":"1434_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2967\/jnumed.118.215913","volume":"60","author":"FL Giesel","year":"2019","unstructured":"Giesel FL, Kratochwil C, Lindner T, Marschalek MM, Loktev A, Lehnert W, et al. 68Ga-FAPI PET\/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers. J nucl med. 2019;60:386\u201392.","journal-title":"J nucl med"},{"key":"1434_CR12","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1007\/s00259-020-04818-7","volume":"47","author":"L Zhao","year":"2020","unstructured":"Zhao L, Chen S, Lin L, Sun L, Wu H, Lin Q, et al. [68Ga]Ga-DOTA-FAPI-04 improves tumor staging and monitors early response to chemoradiotherapy in a patient with esophageal cancer. Eur j nucl med mol i. 2020;47:3188\u20139.","journal-title":"Eur j nucl med mol i"},{"key":"1434_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5230\/jgc.2014.14.1.1","volume":"14","author":"M Yun","year":"2014","unstructured":"Yun M. Imaging of Gastric Cancer Metabolism Using 18 F-FDG PET\/CT. J Gastric Cancer. 2014;14:1\u20136.","journal-title":"J Gastric Cancer"},{"key":"1434_CR14","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","volume":"59","author":"A Loktev","year":"2018","unstructured":"Loktev A, Lindner T, Mier W, Debus J, Altmann A, J\u00e4ger D, et al. A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts. J Nucl Med. 2018;59:1423\u20139.","journal-title":"J Nucl Med"},{"key":"1434_CR15","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2967\/jnumed.119.237016","volume":"61","author":"SA Koerber","year":"2020","unstructured":"Koerber SA, Staudinger F, Kratochwil C, Adeberg S, Haefner MF, Ungerechts G, et al. The Role of 68Ga-FAPI PET\/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience. J Nucl Med. 2020;61:1331\u20136.","journal-title":"J Nucl Med"},{"key":"1434_CR16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/prca.201300095","volume":"8","author":"EJ Hamson","year":"2014","unstructured":"Hamson EJ, Keane FM, Tholen S, Schilling O, Gorrell MD. Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy. Proteomics Clin Appl. 2014;8:454\u201363.","journal-title":"Proteomics Clin Appl"},{"key":"1434_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s00259-020-04882-z","volume":"48","author":"X Shi","year":"2021","unstructured":"Shi X, Xing H, Yang X, Li F, Yao S, Zhang H, et al. Fibroblast imaging of hepatic carcinoma with 68Ga-FAPI-04 PET\/CT: a pilot study in patients with suspected hepatic nodules. Eur j nucl med mol i. 2021;48:196\u2013203.","journal-title":"Eur j nucl med mol i"},{"key":"1434_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/RLU.0000000000004012","volume":"47","author":"D Peng","year":"2022","unstructured":"Peng D, Wu J, Zhang T, Chen Y, Hu Z. Increased 68Ga-FAPI uptake by mediastinal benign teratoma on 68Ga-FAPI PET\/CT. Clin Nucl Med. 2022;47:437\u20138.","journal-title":"Clin Nucl Med"},{"key":"1434_CR19","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1007\/s00259-020-05146-6","volume":"48","author":"L Zhao","year":"2021","unstructured":"Zhao L, Pang Y, Luo Z, Fu K, Yang T, Zhao L, et al. Role of [68Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET\/CT. Eur j nucl med mol i. 2021;48:1944\u201355.","journal-title":"Eur j nucl med mol i"},{"key":"1434_CR20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.dld.2021.07.011","volume":"54","author":"D Peng","year":"2022","unstructured":"Peng D, He J, Liu H, Cao J, Wang Y, Chen Y. FAPI PET\/CT research progress in digestive system tumours. Dig Liver Dis. 2022;54:164\u20139.","journal-title":"Dig Liver Dis"},{"key":"1434_CR21","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00259-020-05070-9","volume":"48","author":"X Shi","year":"2021","unstructured":"Shi X, Xing H, Yang X, Li F, Yao S, Congwei J, et al. Comparison of PET imaging of activated fibroblasts and 18F-FDG for diagnosis of primary hepatic tumours: a prospective pilot study. Eur j nucl med mol i. 2021;48:1593\u2013603.","journal-title":"Eur j nucl med mol i"},{"key":"1434_CR22","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/RLU.0000000000003056","volume":"45","author":"Y Pang","year":"2020","unstructured":"Pang Y, Hao B, Shang Q, Sun L, Chen H. Comparison of 68Ga-FAPI and 18F-FDG PET\/CT in a patient with cholangiocellular carcinoma: a case report. Clin Nucl Med. 2020;45:566\u20137.","journal-title":"Clin Nucl Med"},{"key":"1434_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030547","author":"D Giannis","year":"2021","unstructured":"Giannis D, Cerullo M, Moris D, Shah KN, Herbert G, Zani S, et al. Validation of the 8th edition American Joint Commission on Cancer (AJCC) gallbladder cancer staging system: prognostic discrimination and identification of key predictive factors. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13030547.","journal-title":"Cancers (Basel)"},{"key":"1434_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106234","volume":"98","author":"CF Feo","year":"2022","unstructured":"Feo CF, Ginesu GC, Fancellu A, Perra T, Ninniri C, Deiana G, et al. Current management of incidental gallbladder cancer: a review. Int J Surg. 2022;98:106234.","journal-title":"Int J Surg"},{"key":"1434_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1148\/radiol.211424","volume":"303","author":"L Wang","year":"2022","unstructured":"Wang L, Tang G, Hu K, Liu X, Zhou W, Li H, et al. Comparison of 68Ga-FAPI and 18F-FDG PET\/CT in the Evaluation of Advanced Lung Cancer. Radiology. 2022;303:191\u20139.","journal-title":"Radiology"},{"key":"1434_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2025.111195","volume":"213","author":"X Bai","year":"2025","unstructured":"Bai X, Zhang N, Liu H, Xie Y, Gao B, Xu T, et al. A preliminary study on the safety and efficacy of 177Lu-FAP-2286 in gastrointestinal tumours with positive FAP expression. Radiother Oncol. 2025;213:111195.","journal-title":"Radiother Oncol"},{"key":"1434_CR27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.271317","author":"L Li","year":"2026","unstructured":"Li L, Ding H, Chen L, Zheng W, Zhang Y, Chen Y. Initial results and clinical experiences of [177Lu]Lu-FAP-2286 for pleural metastases: a single-center retrospective study. J Nucl Med. 2026. https:\/\/doi.org\/10.2967\/jnumed.125.271317.","journal-title":"J Nucl Med"},{"key":"1434_CR28","doi-asserted-by":"publisher","unstructured":"LiuW, Zhang N, Zheng W, Xu T, Huang D, Liu Z et al. Comparative evaluation of [68Ga]Ga-FAP-2286 and [18F]FDG PET\/CT in breast cancer and initial experience with [177Lu]Lu-FAP-2286 therapy. Eur J Nucl Med Mol Imaging. 2026. https:\/\/doi.org\/10.1007\/s00259-026-07766-w.","DOI":"10.1007\/s00259-026-07766-w"},{"key":"1434_CR29","doi-asserted-by":"publisher","first-page":"e0116683","DOI":"10.1371\/journal.pone.0116683","volume":"10","author":"F Liu","year":"2015","unstructured":"Liu F, Qi L, Liu B, Liu J, Zhang H, Che D, et al. Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis. PLoS One. 2015;10:e0116683.","journal-title":"PLoS One"},{"key":"1434_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12020577","author":"Z Cheng","year":"2023","unstructured":"Cheng Z, Wang S, Xu S, Du B, Li X, Li Y. FAPI PET\/CT in diagnostic and treatment management of colorectal cancer: review of current research status. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12020577.","journal-title":"J Clin Med"},{"key":"1434_CR31","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.222448","volume":"307","author":"D Peng","year":"2023","unstructured":"Peng D, Cao J, Guo C, He J, Yang L, Zhang J, et al. Influence of Cirrhosis on 68Ga-FAPI PET\/CT in Intrahepatic Tumors. Radiology. 2023;307:e222448.","journal-title":"Radiology"},{"key":"1434_CR32","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1097\/00006231-200112000-00002","volume":"22","author":"A Fritscher-Ravens","year":"2001","unstructured":"Fritscher-Ravens A, Bohuslavizki KH, Broering DC, Jenicke L, Sch\u00e4fer H, Buchert R, et al. FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun. 2001;22:1277\u201385.","journal-title":"Nucl Med Commun"},{"key":"1434_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.semcdb.2009.10.010","volume":"21","author":"OE Franco","year":"2010","unstructured":"Franco OE, Shaw AK, Strand DW, Hayward SW. Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol. 2010;21:33\u20139.","journal-title":"Semin Cell Dev Biol"},{"key":"1434_CR34","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.1007\/s00330-018-5469-0","volume":"28","author":"K Sivesgaard","year":"2018","unstructured":"Sivesgaard K, Larsen LP, S\u00f8rensen M, Kramer S, Schlander S, Amanavicius N, et al. Diagnostic accuracy of CE-CT, MRI and FDG PET\/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and\/or local ablation. Eur Radiol. 2018;28:4735\u201347.","journal-title":"Eur Radiol"},{"key":"1434_CR35","first-page":"213","volume":"44","author":"CL Ho","year":"2003","unstructured":"Ho CL, Yu SC, Yeung DW. 11\u00a0C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med. 2003;44:213\u201321.","journal-title":"J Nucl Med"},{"key":"1434_CR36","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1007\/s00259-020-04866-z","volume":"47","author":"H Chen","year":"2020","unstructured":"Chen H, Wu H. Reply: [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancer. Eur J Nucl Med Mol Imaging. 2020;47:2080\u20132.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1434_CR37","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1007\/s00259-021-05247-w","volume":"48","author":"H Wang","year":"2021","unstructured":"Wang H, Du Z, Huang Q, Ren S, Guan Y, Xie F, et al. The superiority of [68Ga]Ga-FAPI-04 over [18F]-FDG in a case of neuroendocrine tumour with hepatic metastasis. Eur J Nucl Med Mol Imaging. 2021;48:3005\u20136.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1434_CR38","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.2967\/jnumed.123.265751","volume":"64","author":"TT Demmert","year":"2023","unstructured":"Demmert TT, Pomykala KL, Lanzafame H, Pabst KM, Lueckerath K, Siveke J, et al. Oncologic Staging with 68Ga-FAPI PET\/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than 18F-FDG PET\/CT. J nucl med. 2023;64:1906\u20139.","journal-title":"J nucl med"},{"key":"1434_CR39","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20170519","volume":"91","author":"SJ Kim","year":"2018","unstructured":"Kim SJ, Lee SW. Diagnostic accuracy of 18F-FDG PET\/CT for detection of peritoneal carcinomatosis; a systematic review and meta-analysis. Br J Radiol. 2018;91:20170519.","journal-title":"Br J Radiol"},{"key":"1434_CR40","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s00259-025-07372-2","volume":"53","author":"W Ma","year":"2025","unstructured":"Ma W, Yang S, Ye J, Quan Z, Zhang M, Li G, et al. Head-to-head comparison of 68Ga-FT-FAPI with 68Ga-FAPI-04 in patients with gastrointestinal tumors. Eur j nucl med mol i. 2025;53:158\u201366.","journal-title":"Eur j nucl med mol i"},{"key":"1434_CR41","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1007\/s00259-022-05799-5","volume":"49","author":"R Lin","year":"2022","unstructured":"Lin R, Lin Z, Chen Z, Zheng S, Zhang J, Zang J, et al. [68Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of gastric cancer: comparison with [18F]FDG PET\/CT. Eur j nucl med mol i. 2022;49:2960\u201371.","journal-title":"Eur j nucl med mol i"},{"key":"1434_CR42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00432-025-06237-3","volume":"151","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Zhao Y, Shuai D, Yang X, Hu Q, Deng X, et al. Comparison of 68Ga-FAPI-04 PET\/CT with CECT in the evaluation of peritoneal metastases from gastrointestinal cancers and impact on clinical decision-making. J Cancer Res Clin Oncol. 2025;151:201.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1434_CR43","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2967\/jnumed.120.259192","volume":"63","author":"RP Baum","year":"2022","unstructured":"Baum RP, Schuchardt C, Singh A, Chantadisai M, Robiller FC, Zhang J, et al. Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results. J nucl med. 2022;63:415\u201323.","journal-title":"J nucl med"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-026-01434-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01434-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01434-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:54:11Z","timestamp":1780448051000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13550-026-01434-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1434"],"URL":"https:\/\/doi.org\/10.1186\/s13550-026-01434-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8069247\/v1","asserted-by":"object"}]},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Affiliated Hospital of Southwest Medical University (2020035). All procedures involving human participants were performed in accordance with the ethical standards of the institutional committee, as well as the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study does not contain any animal experiments. Informed consent was obtained from all participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors affirm that all human participants involved in this study have signed the consent form and agreed to the publication of their medical imaging.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Each author declares that he has no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}